Author:
O'Connor James P. B.,Jackson Alan,Parker Geoff J. M.,Roberts Caleb,Jayson Gordon C.
Publisher
Springer Science and Business Media LLC
Reference111 articles.
1. Collins, J. M. Functional imaging in phase I studies: decorations or decision making? J. Clin. Oncol. 21, 2807–2809 (2003).
2. O'Connor, J. P., Jackson, A., Parker, G. J. & Jayson, G. C. DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br. J. Cancer 96, 189–195 (2007).
3. Zweifel, M. & Padhani, A. R. Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools? Eur. J. Nucl. Med. Mol. Imaging 37 (Suppl. 1), 164–182 (2010).
4. Tofts, P. S. et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J. Magn. Reson. Imaging 10, 223–232 (1999).
5. Dowlati, A. et al. A phase I pharmacokinetic and translational study of the novel vascular targeting agent combretastatin a-4 phosphate on a single-dose intravenous schedule in patients with advanced cancer. Cancer Res. 62, 3408–3416 (2002).
Cited by
308 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献